MGX (Metagenomi Therapeutics) Yalpi foyda bo'yicha rentabellik

Metagenomi Therapeutics (MGX) kompaniyasining rasmiy ramzlari

Metagenomi, Inc. (MGX) qat'iy FDA nazorati va patent to'siqlari tufayli yuzaga keladigan xavflarga duch kelmoqda, bu esa yalpi foyda marjasining tebranishlarini keltirib chiqaradi. Parametrning joriy qiymati 28.10 ni tashkil etadi. Aktivning barqarorligi klinik sinovlarning muvaffaqiyati va sog'liqni saqlash gigantlari bilan hamkorlikka bog'liq. Kompaniyaning AI asosidagi genom tahrirlash sohasidagi yuqori nufuzi va ilmiy yetakchi sifatidagi maqomi biznes qiymati o'sishi uchun mustahkam poydevor yaratadi.

MGX Metagenomi Yalpi rentabellik (21.02.2024 - 20.11.2026)

Metagenomi (MGX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- kotirovkalar va tahlilchilar prognozi:
Fundamental baholash:Metagenomi Inc.
metagenomi.co original mahsuloti

Yalpi foyda marjasi mahsulotni yaratish xarajatlaridan keyin qolgan daromad qismini aniqlash orqali bevosita ishlab chiqarish samaradorligini o'lchaydi. Yalpi foyda marjasi dinamikasi operatsion barqarorlikni aks ettiradi, bu esa daromad olmagan platforma bo'lgan Metagenomi, Inc. (MGX) uchun genom tahrirlash texnologiyalarini ishlab chiqish davrida investitsiya kapitaliga bog'liqlikni anglatadi, bu davrda an'anaviy daromadlilik ko'rsatkichlari vaqtincha strategik kapitalni rivojlantirishga yo'l ochadi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi marja SLN|ProQR Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja CDXS (Codexis, Inc.)|SGMO: Sotuvning yalpi rentabelligi|Nautilus Biotechnology - Yalpi marja|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik